Related News
Home » Metro » Health and Science
Quintiles to open bio-medicine lab in Shanghai
By Cai Wenjun |
June 18, 2012, Monday
|
Online Edition
Online Edition
THE state-owned Shanghai Clinical Research Center today signed an agreement with the US-based Quintiles, the world's largest bio-pharmaceutical services provider, to set up a joint venture lab to boost new drug development in China.
Chronic diseases common among elderly people will be a focus of research at the new laboratory in Shanghai, said Qunintiles, which will invest US$14 million in its China headquarters and local lab in the Fenglin Life Science Park in Xuhui District and hire about 450 employees in the next five years.
In addition to developing new drugs, the lab will also tap the potentials of traditional Chinese medicine in pharmaceutical research and development.
Chronic diseases common among elderly people will be a focus of research at the new laboratory in Shanghai, said Qunintiles, which will invest US$14 million in its China headquarters and local lab in the Fenglin Life Science Park in Xuhui District and hire about 450 employees in the next five years.
In addition to developing new drugs, the lab will also tap the potentials of traditional Chinese medicine in pharmaceutical research and development.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
